These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 11078525)

  • 1. A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR).
    Chan TF; Carvalho J; Riles L; Zheng XF
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13227-32. PubMed ID: 11078525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOR regulates ribosomal protein gene expression via PKA and the Forkhead transcription factor FHL1.
    Martin DE; Soulard A; Hall MN
    Cell; 2004 Dec; 119(7):969-79. PubMed ID: 15620355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of translation by the target of rapamycin proteins.
    Gingras AC; Raught B; Sonenberg N
    Prog Mol Subcell Biol; 2001; 27():143-74. PubMed ID: 11575159
    [No Abstract]   [Full Text] [Related]  

  • 4. Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway.
    Butcher RA; Bhullar BS; Perlstein EO; Marsischky G; LaBaer J; Schreiber SL
    Nat Chem Biol; 2006 Feb; 2(2):103-9. PubMed ID: 16415861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
    Alarcon CM; Heitman J; Cardenas ME
    Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae.
    Powers T; Walter P
    Mol Biol Cell; 1999 Apr; 10(4):987-1000. PubMed ID: 10198052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease.
    Schmidt A; Beck T; Koller A; Kunz J; Hall MN
    EMBO J; 1998 Dec; 17(23):6924-31. PubMed ID: 9843498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.
    Loewith R; Jacinto E; Wullschleger S; Lorberg A; Crespo JL; Bonenfant D; Oppliger W; Jenoe P; Hall MN
    Mol Cell; 2002 Sep; 10(3):457-68. PubMed ID: 12408816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TOR-controlled transcription activators GLN3, RTG1, and RTG3 are regulated in response to intracellular levels of glutamine.
    Crespo JL; Powers T; Fowler B; Hall MN
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6784-9. PubMed ID: 11997479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.
    Crespo JL; Hall MN
    Microbiol Mol Biol Rev; 2002 Dec; 66(4):579-91, table of contents. PubMed ID: 12456783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partitioning the transcriptional program induced by rapamycin among the effectors of the Tor proteins.
    Shamji AF; Kuruvilla FG; Schreiber SL
    Curr Biol; 2000 Dec 14-28; 10(24):1574-81. PubMed ID: 11137008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.
    Zheng XF; Florentino D; Chen J; Crabtree GR; Schreiber SL
    Cell; 1995 Jul; 82(1):121-30. PubMed ID: 7606777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
    Lorenz MC; Heitman J
    J Biol Chem; 1995 Nov; 270(46):27531-7. PubMed ID: 7499212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The target of rapamycin signaling pathway regulates mRNA turnover in the yeast Saccharomyces cerevisiae.
    Albig AR; Decker CJ
    Mol Biol Cell; 2001 Nov; 12(11):3428-38. PubMed ID: 11694578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quick guide: target of rapamycin.
    Dennis PB; Thomas G
    Curr Biol; 2002 Apr; 12(8):R269. PubMed ID: 11967163
    [No Abstract]   [Full Text] [Related]  

  • 16. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation.
    Dennis PB; Fumagalli S; Thomas G
    Curr Opin Genet Dev; 1999 Feb; 9(1):49-54. PubMed ID: 10072357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of TOR and its complex with KOG1.
    Adami A; García-Alvarez B; Arias-Palomo E; Barford D; Llorca O
    Mol Cell; 2007 Aug; 27(3):509-16. PubMed ID: 17679098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TOR and EGO protein complexes orchestrate microautophagy in yeast.
    Dubouloz F; Deloche O; Wanke V; Cameroni E; De Virgilio C
    Mol Cell; 2005 Jul; 19(1):15-26. PubMed ID: 15989961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases.
    Di Como CJ; Arndt KT
    Genes Dev; 1996 Aug; 10(15):1904-16. PubMed ID: 8756348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TOR modulates GCN4-dependent expression of genes turned on by nitrogen limitation.
    Valenzuela L; Aranda C; González A
    J Bacteriol; 2001 Apr; 183(7):2331-4. PubMed ID: 11244074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.